Literature DB >> 24623275

Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.

Jung Wook Huh1, Hee Cheol Kim, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun.   

Abstract

BACKGROUND: The aim of this study was to evaluate the predictive role of the mismatch repair (MMR) system and p53 expression for lymph node metastasis and long-term survival in patients with T1 and T2 colorectal cancer.
METHODS: A total of 543 patients with T1 or T2 colorectal cancers who underwent radical surgery with regional lymphadenectomy from December 2007 to December 2009 were analyzed. Predictive factors for lymph node metastasis and prognostic factors were analyzed.
RESULTS: During the median follow-up period of 4 years, the 5-year disease-free survival rate for patients without lymph node metastasis was 94.8%, which was significantly higher than that for those with lymph node metastases (85.2%; P < 0.001). On multivariate analysis, gender, tumor location, N category, lymphatic invasion, vascular invasion, and perineural invasion were independent prognostic factors for disease-free survival; however MMR defect, p53 expression, and microsatellite instability (MSI) were not. The presence of lymphatic invasion, vascular invasion, and tumor budding were independent predictors of lymph node metastasis.
CONCLUSIONS: In patients with T1 or T2 colorectal cancer, lymphatic invasion, vascular invasion, and tumor budding were predictive of lymph node metastasis; however, MMR defect, p53 expression, and MSI were not predictive.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  early colorectal cancer; lymph node metastasis; prognostic factor

Mesh:

Substances:

Year:  2014        PMID: 24623275     DOI: 10.1002/jso.23592

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer.

Authors:  Jung Wook Huh; Seong Hyeon Yun; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Hee Cheol Kim; Woo Yong Lee; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  J Gastrointest Surg       Date:  2018-05-29       Impact factor: 3.452

2.  Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.

Authors:  David S Williams; Dmitri Mouradov; Clare Browne; Michelle Palmieri; Meg J Elliott; Rebecca Nightingale; Catherine G Fang; Rita Li; John M Mariadason; Ian Faragher; Ian T Jones; Leonid Churilov; Niall C Tebbutt; Peter Gibbs; Oliver M Sieber
Journal:  Mod Pathol       Date:  2019-08-30       Impact factor: 7.842

Review 3.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

4.  Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.

Authors:  Zhen-Qiang Sun; Shuai Ma; Quan-Bo Zhou; Shuai-Xi Yang; Yuan Chang; Xiang-Yue Zeng; Wei-Guo Ren; Fang-Hai Han; Xiang Xie; Fan-Ye Zeng; Xian-Tao Sun; Gui-Xian Wang; Zhen Li; Zhi-Yong Zhang; Jun-Min Song; Jin-Bo Liu; Wei-Tang Yuan
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

5.  The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings.

Authors:  Qiang Feng; Hong Yu; Shihang Sun; Zhijun Ma
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

6.  Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.

Authors:  Jeong-Ki Kim; Ye-Young Rhee; Jeong Mo Bae; Jung Ho Kim; Seong-Joon Koh; Hyun Jung Lee; Jong Pil Im; Min Jung Kim; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park; Ji Won Park; Gyeong Hoon Kang
Journal:  BMC Cancer       Date:  2022-08-06       Impact factor: 4.638

7.  Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.

Authors:  Jiao Yang; Xiang Lin Du; Shu Ting Li; Bi Yuan Wang; Yin Ying Wu; Zhe Ling Chen; Meng Lv; Yan Wei Shen; Xin Wang; Dan Feng Dong; Dan Li; Fan Wang; En Xiao Li; Min Yi; Jin Yang
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation.

Authors:  Jung Wook Huh; Hee Cheol Kim; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Woo Yong Lee; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

9.  Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.

Authors:  Chao Yang; Fengyu Cao; Shuoyang Huang; Yongbin Zheng
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.